

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.55529643 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.48054491 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.48054491 |
| 4 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.43141409 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.04711650 |
| 6 | response to muramyl dipeptide (GO:0032495) | 3.99030003 |
| 7 | negative thymic T cell selection (GO:0045060) | 3.90326861 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 3.83191710 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.78523838 |
| 10 | positive thymic T cell selection (GO:0045059) | 3.78077338 |
| 11 | negative T cell selection (GO:0043383) | 3.77156037 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 3.64324972 |
| 13 | NIK/NF-kappaB signaling (GO:0038061) | 3.52414894 |
| 14 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.51619204 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 3.46897100 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 3.46897100 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.46897100 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.46897100 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.46897100 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 3.46897100 |
| 21 | hepatocyte apoptotic process (GO:0097284) | 3.46122215 |
| 22 | cellular extravasation (GO:0045123) | 3.43511073 |
| 23 | response to peptidoglycan (GO:0032494) | 3.33685449 |
| 24 | neutrophil activation (GO:0042119) | 3.30268380 |
| 25 | microglial cell activation (GO:0001774) | 3.28695408 |
| 26 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.25339966 |
| 27 | negative regulation of T cell mediated immunity (GO:0002710) | 3.21138575 |
| 28 | positive T cell selection (GO:0043368) | 3.19331506 |
| 29 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.17537201 |
| 30 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.17537201 |
| 31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.17124302 |
| 32 | negative regulation of bone resorption (GO:0045779) | 3.16519665 |
| 33 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.15465036 |
| 34 | cellular response to interleukin-15 (GO:0071350) | 3.14343321 |
| 35 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.13152734 |
| 36 | granulocyte activation (GO:0036230) | 3.12452259 |
| 37 | response to interleukin-15 (GO:0070672) | 3.09320372 |
| 38 | thymic T cell selection (GO:0045061) | 3.09226774 |
| 39 | negative regulation of innate immune response (GO:0045824) | 3.08807383 |
| 40 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.06170469 |
| 41 | positive regulation of interferon-alpha production (GO:0032727) | 3.04298785 |
| 42 | regulation of regulatory T cell differentiation (GO:0045589) | 3.04178574 |
| 43 | macrophage activation (GO:0042116) | 3.02192448 |
| 44 | dendritic cell chemotaxis (GO:0002407) | 3.02149500 |
| 45 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.00758267 |
| 46 | positive regulation of antigen processing and presentation (GO:0002579) | 2.99937767 |
| 47 | energy homeostasis (GO:0097009) | 2.99451910 |
| 48 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.99210514 |
| 49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.99210514 |
| 50 | monocyte chemotaxis (GO:0002548) | 2.99074620 |
| 51 | T cell selection (GO:0045058) | 2.96692887 |
| 52 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.96205974 |
| 53 | cellular response to exogenous dsRNA (GO:0071360) | 2.95509518 |
| 54 | macrophage activation involved in immune response (GO:0002281) | 2.94427498 |
| 55 | B cell receptor signaling pathway (GO:0050853) | 2.93316543 |
| 56 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.93077773 |
| 57 | negative regulation of interleukin-12 production (GO:0032695) | 2.93049181 |
| 58 | regulation of interferon-alpha production (GO:0032647) | 2.91825059 |
| 59 | negative regulation of interleukin-6 production (GO:0032715) | 2.91536399 |
| 60 | germinal center formation (GO:0002467) | 2.90484532 |
| 61 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.90442281 |
| 62 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.89937431 |
| 63 | detection of other organism (GO:0098543) | 2.86853807 |
| 64 | negative regulation of interleukin-8 production (GO:0032717) | 2.86586579 |
| 65 | response to type I interferon (GO:0034340) | 2.86568940 |
| 66 | defense response to protozoan (GO:0042832) | 2.86142979 |
| 67 | type I interferon signaling pathway (GO:0060337) | 2.85659152 |
| 68 | cellular response to type I interferon (GO:0071357) | 2.85659152 |
| 69 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.85405299 |
| 70 | myeloid dendritic cell activation (GO:0001773) | 2.84667271 |
| 71 | dendritic cell migration (GO:0036336) | 2.83665290 |
| 72 | leukocyte aggregation (GO:0070486) | 2.82759245 |
| 73 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.82596285 |
| 74 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.82541173 |
| 75 | T cell migration (GO:0072678) | 2.80459228 |
| 76 | positive regulation of interleukin-12 production (GO:0032735) | 2.80392184 |
| 77 | myeloid dendritic cell differentiation (GO:0043011) | 2.78599560 |
| 78 | regulation of B cell differentiation (GO:0045577) | 2.78305964 |
| 79 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.78209281 |
| 80 | negative regulation of type 2 immune response (GO:0002829) | 2.77874751 |
| 81 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.75858762 |
| 82 | detection of bacterium (GO:0016045) | 2.75803662 |
| 83 | mast cell activation (GO:0045576) | 2.75270773 |
| 84 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.75138801 |
| 85 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.75126922 |
| 86 | growth hormone receptor signaling pathway (GO:0060396) | 2.75088038 |
| 87 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.73310130 |
| 88 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.72835108 |
| 89 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.71134996 |
| 90 | respiratory burst (GO:0045730) | 2.68771982 |
| 91 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.68589682 |
| 92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.68386568 |
| 93 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.67612561 |
| 94 | positive regulation of B cell differentiation (GO:0045579) | 2.67450518 |
| 95 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.66756251 |
| 96 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.66640729 |
| 97 | regulation of chemokine secretion (GO:0090196) | 2.66407742 |
| 98 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.66001342 |
| 99 | regulation of antigen processing and presentation (GO:0002577) | 2.65880720 |
| 100 | regulation of T-helper 1 type immune response (GO:0002825) | 2.65876134 |
| 101 | myeloid leukocyte activation (GO:0002274) | 2.64927651 |
| 102 | positive regulation of T cell differentiation (GO:0045582) | 2.64629432 |
| 103 | positive regulation of tolerance induction (GO:0002645) | 2.64595306 |
| 104 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.63855916 |
| 105 | myeloid cell activation involved in immune response (GO:0002275) | 2.63746827 |
| 106 | regulation of tolerance induction (GO:0002643) | 2.63696407 |
| 107 | regulation of alpha-beta T cell activation (GO:0046634) | 2.63324178 |
| 108 | B cell homeostasis (GO:0001782) | 2.62304210 |
| 109 | regulation of alpha-beta T cell differentiation (GO:0046637) | 2.59623305 |
| 110 | T-helper cell differentiation (GO:0042093) | 2.58291067 |
| 111 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.58291067 |
| 112 | response to host immune response (GO:0052572) | 2.58054546 |
| 113 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.58054546 |
| 114 | positive regulation of type 2 immune response (GO:0002830) | 2.56478473 |
| 115 | regulation of RIG-I signaling pathway (GO:0039535) | 2.55569834 |
| 116 | negative regulation of lipid storage (GO:0010888) | 2.55550153 |
| 117 | regulation of T cell tolerance induction (GO:0002664) | 2.53905487 |
| 118 | dendritic cell differentiation (GO:0097028) | 2.49996341 |
| 119 | regulation of fibroblast apoptotic process (GO:2000269) | 2.49263041 |
| 120 | immunoglobulin mediated immune response (GO:0016064) | 2.48665254 |
| 121 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.48619168 |
| 122 | cell adhesion mediated by integrin (GO:0033627) | 2.46200959 |
| 123 | cytokine secretion (GO:0050663) | 2.45321700 |
| 124 | natural killer cell mediated immunity (GO:0002228) | 2.42472277 |
| 125 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.42472277 |
| 126 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.42206854 |
| 127 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.40287562 |
| 128 | lymphocyte chemotaxis (GO:0048247) | 2.40170785 |
| 129 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.39819665 |
| 130 | interferon-gamma secretion (GO:0072643) | 2.39762141 |
| 131 | wound healing, spreading of epidermal cells (GO:0035313) | 2.36398349 |
| 132 | response to host (GO:0075136) | 2.35130061 |
| 133 | response to host defenses (GO:0052200) | 2.35130061 |
| 134 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.35130061 |
| 135 | T cell activation involved in immune response (GO:0002286) | 2.35039520 |
| 136 | superoxide anion generation (GO:0042554) | 2.32775955 |
| 137 | cellular response to growth hormone stimulus (GO:0071378) | 2.31499540 |
| 138 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.30339076 |
| 139 | response to protozoan (GO:0001562) | 2.29909426 |
| 140 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.29216591 |
| 141 | regulation of germinal center formation (GO:0002634) | 2.28799727 |
| 142 | positive regulation of heat generation (GO:0031652) | 2.28665851 |
| 143 | positive regulation of interferon-beta production (GO:0032728) | 2.28529594 |
| 144 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.28245815 |
| 145 | positive regulation of p38MAPK cascade (GO:1900745) | 2.28216054 |
| 146 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.27216901 |
| 147 | regulation of interleukin-12 production (GO:0032655) | 2.26877086 |
| 148 | establishment of endothelial barrier (GO:0061028) | 2.25952586 |
| 149 | detection of molecule of bacterial origin (GO:0032490) | 2.25536327 |
| 150 | tolerance induction (GO:0002507) | 2.25410038 |
| 151 | response to laminar fluid shear stress (GO:0034616) | 2.24968736 |
| 152 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.23386279 |
| 153 | positive regulation of acute inflammatory response (GO:0002675) | 2.23035990 |
| 154 | regulation of mononuclear cell migration (GO:0071675) | 2.22507493 |
| 155 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.22070241 |
| 156 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.21989074 |
| 157 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.21937820 |
| 158 | negative regulation of granulocyte differentiation (GO:0030853) | 2.21802195 |
| 159 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.21467395 |
| 160 | T cell differentiation involved in immune response (GO:0002292) | 2.21467395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.02942139 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.74728046 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.71220575 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.21469685 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.52506970 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.48905880 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.37545246 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.10510158 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.97197123 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.87392267 |
| 11 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.82269033 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81545964 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.75658446 |
| 14 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.70200107 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.53001312 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.44116250 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42919844 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.41239863 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.35514944 |
| 20 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.34059881 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.22139013 |
| 22 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.04503101 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.00107245 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99621112 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.97693809 |
| 26 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.97508311 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89572722 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.89182370 |
| 29 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.79934469 |
| 30 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.76983340 |
| 31 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.76983340 |
| 32 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74975962 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.72845638 |
| 34 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.71125709 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68843375 |
| 36 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66075256 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65920789 |
| 38 | CJUN_26792858_Chip-Seq_BT549_Human | 1.65052917 |
| 39 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.58723433 |
| 40 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.57131317 |
| 41 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.54238558 |
| 42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51479129 |
| 43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.47689934 |
| 44 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47482279 |
| 45 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.47014801 |
| 46 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.46583954 |
| 47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.43706362 |
| 48 | * MYB_26560356_Chip-Seq_TH2_Human | 1.43631969 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42414364 |
| 50 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40509319 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.39958445 |
| 52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.39590905 |
| 53 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.39376968 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39345540 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38973330 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37278594 |
| 57 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.35949223 |
| 58 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.35452699 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34972043 |
| 60 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.32812630 |
| 61 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.32812630 |
| 62 | MYC_22102868_ChIP-Seq_BL_Human | 1.32282811 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.29987181 |
| 64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29619400 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.26009367 |
| 66 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25141762 |
| 67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24919224 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24666376 |
| 69 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24179344 |
| 70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23862355 |
| 71 | MAF_26560356_Chip-Seq_TH2_Human | 1.22198618 |
| 72 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21495562 |
| 73 | * MAF_26560356_Chip-Seq_TH1_Human | 1.21354878 |
| 74 | * MYB_26560356_Chip-Seq_TH1_Human | 1.20470875 |
| 75 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.17363076 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16382822 |
| 77 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16291332 |
| 78 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15094200 |
| 79 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13909566 |
| 80 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.13110521 |
| 81 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12674161 |
| 82 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.10203860 |
| 83 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09934262 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09311312 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08462761 |
| 86 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06922298 |
| 87 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05864611 |
| 88 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.05525634 |
| 89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04514003 |
| 90 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04411996 |
| 91 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02977530 |
| 92 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02646521 |
| 93 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.01916109 |
| 94 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.01916109 |
| 95 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.01916109 |
| 96 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01388268 |
| 97 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01324278 |
| 98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00899690 |
| 99 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00032323 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99065338 |
| 101 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98640268 |
| 102 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97936609 |
| 103 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.96129828 |
| 104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95084872 |
| 105 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93520375 |
| 106 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.93307582 |
| 107 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92610112 |
| 108 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92458862 |
| 109 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91899766 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90246049 |
| 111 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.89552986 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88544715 |
| 113 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86983624 |
| 114 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.85845102 |
| 115 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.85751855 |
| 116 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.85132273 |
| 117 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.83265310 |
| 118 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.80825606 |
| 119 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.80044732 |
| 120 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.79198709 |
| 121 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79190467 |
| 122 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.78505144 |
| 123 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78409164 |
| 124 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78215680 |
| 125 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77717999 |
| 126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77480610 |
| 127 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.77291448 |
| 128 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77124213 |
| 129 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.77101929 |
| 130 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.76986319 |
| 131 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.76646130 |
| 132 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76352270 |
| 133 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.76328415 |
| 134 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.75402876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.38555338 |
| 2 | MP0002254_reproductive_system_inflammat | 3.37287951 |
| 3 | MP0003436_decreased_susceptibility_to | 3.11867299 |
| 4 | MP0003724_increased_susceptibility_to | 2.91211920 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.59758407 |
| 6 | MP0009785_altered_susceptibility_to | 2.52448752 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.47566815 |
| 8 | MP0005387_immune_system_phenotype | 2.32751014 |
| 9 | MP0001790_abnormal_immune_system | 2.32751014 |
| 10 | MP0002419_abnormal_innate_immunity | 2.32448214 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.18020559 |
| 12 | MP0006082_CNS_inflammation | 2.16673506 |
| 13 | MP0003303_peritoneal_inflammation | 2.16241244 |
| 14 | MP0000685_abnormal_immune_system | 2.16145880 |
| 15 | MP0005671_abnormal_response_to | 2.15937517 |
| 16 | MP0002877_abnormal_melanocyte_morpholog | 2.12244047 |
| 17 | MP0001800_abnormal_humoral_immune | 2.08397004 |
| 18 | MP0001533_abnormal_skeleton_physiology | 2.04702674 |
| 19 | MP0004510_myositis | 2.01709373 |
| 20 | MP0002723_abnormal_immune_serum | 1.97518219 |
| 21 | MP0005025_abnormal_response_to | 1.95469906 |
| 22 | MP0004947_skin_inflammation | 1.94580150 |
| 23 | MP0002405_respiratory_system_inflammati | 1.93848788 |
| 24 | MP0001853_heart_inflammation | 1.90954433 |
| 25 | MP0009278_abnormal_bone_marrow | 1.83388825 |
| 26 | MP0002009_preneoplasia | 1.83079009 |
| 27 | MP0001819_abnormal_immune_cell | 1.82305461 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.82117718 |
| 29 | MP0003828_pulmonary_edema | 1.81537115 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.79186996 |
| 31 | MP0002006_tumorigenesis | 1.76485522 |
| 32 | MP0001346_abnormal_lacrimal_gland | 1.74930577 |
| 33 | MP0003566_abnormal_cell_adhesion | 1.73844414 |
| 34 | MP0003448_altered_tumor_morphology | 1.65618277 |
| 35 | MP0002277_abnormal_respiratory_mucosa | 1.64991010 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.62686952 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.60922281 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.58630486 |
| 39 | MP0001851_eye_inflammation | 1.56457286 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.51390912 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.48216783 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.48039577 |
| 43 | MP0003866_abnormal_defecation | 1.46181465 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.43301888 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.43301888 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.42101692 |
| 47 | MP0003091_abnormal_cell_migration | 1.36552100 |
| 48 | MP0005390_skeleton_phenotype | 1.34862050 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.34518119 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.34389381 |
| 51 | MP0003279_aneurysm | 1.32747931 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.31865148 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.31809118 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.31642436 |
| 55 | MP0000343_altered_response_to | 1.30605607 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.30187651 |
| 57 | MP0003941_abnormal_skin_development | 1.28550833 |
| 58 | MP0005164_abnormal_response_to | 1.27181773 |
| 59 | MP0002060_abnormal_skin_morphology | 1.25980507 |
| 60 | MP0000716_abnormal_immune_system | 1.24563343 |
| 61 | MP0002933_joint_inflammation | 1.23314842 |
| 62 | MP0001873_stomach_inflammation | 1.22236078 |
| 63 | MP0000858_altered_metastatic_potential | 1.20470775 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.19843040 |
| 65 | MP0008438_abnormal_cutaneous_collagen | 1.19711013 |
| 66 | MP0005076_abnormal_cell_differentiation | 1.19559348 |
| 67 | MP0005023_abnormal_wound_healing | 1.19269269 |
| 68 | MP0009764_decreased_sensitivity_to | 1.18914196 |
| 69 | MP0004883_abnormal_blood_vessel | 1.18697210 |
| 70 | MP0009840_abnormal_foam_cell | 1.17855809 |
| 71 | MP0002398_abnormal_bone_marrow | 1.16894976 |
| 72 | MP0001879_abnormal_lymphatic_vessel | 1.15046434 |
| 73 | MP0000383_abnormal_hair_follicle | 1.13327700 |
| 74 | MP0004782_abnormal_surfactant_physiolog | 1.10317461 |
| 75 | MP0005310_abnormal_salivary_gland | 1.05287412 |
| 76 | MP0010368_abnormal_lymphatic_system | 1.04635582 |
| 77 | MP0001216_abnormal_epidermal_layer | 1.01993904 |
| 78 | MP0004381_abnormal_hair_follicle | 0.99352320 |
| 79 | MP0009333_abnormal_splenocyte_physiolog | 0.98732628 |
| 80 | MP0001958_emphysema | 0.98556399 |
| 81 | MP0005275_abnormal_skin_tensile | 0.98290926 |
| 82 | MP0005058_abnormal_lysosome_morphology | 0.98234747 |
| 83 | MP0003045_fibrosis | 0.96851389 |
| 84 | MP0003172_abnormal_lysosome_physiology | 0.96258281 |
| 85 | MP0003075_altered_response_to | 0.96246024 |
| 86 | MP0000767_abnormal_smooth_muscle | 0.95497303 |
| 87 | * MP0002429_abnormal_blood_cell | 0.93306085 |
| 88 | MP0002722_abnormal_immune_system | 0.92183240 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.91879406 |
| 90 | MP0000689_abnormal_spleen_morphology | 0.90666451 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 0.90305314 |
| 92 | MP0005166_decreased_susceptibility_to | 0.89795476 |
| 93 | MP0000249_abnormal_blood_vessel | 0.89450235 |
| 94 | MP0008469_abnormal_protein_level | 0.87604901 |
| 95 | MP0002132_abnormal_respiratory_system | 0.87496094 |
| 96 | MP0001191_abnormal_skin_condition | 0.87481412 |
| 97 | MP0003795_abnormal_bone_structure | 0.86789938 |
| 98 | MP0010678_abnormal_skin_adnexa | 0.86375458 |
| 99 | MP0001542_abnormal_bone_strength | 0.86321138 |
| 100 | MP0000604_amyloidosis | 0.82992646 |
| 101 | MP0002098_abnormal_vibrissa_morphology | 0.81892635 |
| 102 | MP0004484_altered_response_of | 0.81594695 |
| 103 | MP0009763_increased_sensitivity_to | 0.81429921 |
| 104 | MP0003191_abnormal_cellular_cholesterol | 0.78614977 |
| 105 | MP0004272_abnormal_basement_membrane | 0.77743187 |
| 106 | MP0002876_abnormal_thyroid_physiology | 0.74702238 |
| 107 | MP0002928_abnormal_bile_duct | 0.74128398 |
| 108 | MP0003252_abnormal_bile_duct | 0.73752427 |
| 109 | MP0002295_abnormal_pulmonary_circulatio | 0.73370750 |
| 110 | MP0008007_abnormal_cellular_replicative | 0.72997131 |
| 111 | MP0005257_abnormal_intraocular_pressure | 0.72544261 |
| 112 | MP0001243_abnormal_dermal_layer | 0.71535933 |
| 113 | MP0000569_abnormal_digit_pigmentation | 0.71532196 |
| 114 | MP0003950_abnormal_plasma_membrane | 0.66838291 |
| 115 | MP0003183_abnormal_peptide_metabolism | 0.66668287 |
| 116 | MP0008004_abnormal_stomach_pH | 0.66582148 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.61962201 |
| 118 | MP0001663_abnormal_digestive_system | 0.61413069 |
| 119 | MP0005167_abnormal_blood-brain_barrier | 0.55738886 |
| 120 | MP0002133_abnormal_respiratory_system | 0.55390998 |
| 121 | MP0005388_respiratory_system_phenotype | 0.55390998 |
| 122 | MP0001986_abnormal_taste_sensitivity | 0.53788126 |
| 123 | MP0005165_increased_susceptibility_to | 0.52442493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.13309001 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.53753841 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.07625857 |
| 4 | T lymphocytopenia (HP:0005403) | 3.96469702 |
| 5 | IgG deficiency (HP:0004315) | 3.79546471 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 3.78110628 |
| 7 | Orchitis (HP:0100796) | 3.77322684 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.76855808 |
| 9 | Optic neuritis (HP:0100653) | 3.72475689 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 3.72475689 |
| 11 | Myositis (HP:0100614) | 3.60253345 |
| 12 | Abnormality of B cell number (HP:0010975) | 3.59358555 |
| 13 | Abnormality of T cells (HP:0002843) | 3.52113444 |
| 14 | Severe combined immunodeficiency (HP:0004430) | 3.39343325 |
| 15 | Thick nail (HP:0001805) | 3.38209602 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.37350942 |
| 17 | B lymphocytopenia (HP:0010976) | 3.32779490 |
| 18 | Granulocytopenia (HP:0001913) | 3.25332161 |
| 19 | Abnormality of T cell physiology (HP:0011840) | 3.22228207 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.19614613 |
| 21 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.14778494 |
| 22 | Osteolytic defects of the hand bones (HP:0009699) | 3.14778494 |
| 23 | Recurrent fungal infections (HP:0002841) | 3.07959757 |
| 24 | Agammaglobulinemia (HP:0004432) | 3.06212830 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.02419483 |
| 26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.83045551 |
| 27 | Distal lower limb muscle weakness (HP:0009053) | 2.76368645 |
| 28 | Vasculitis (HP:0002633) | 2.73818600 |
| 29 | Recurrent bronchitis (HP:0002837) | 2.70564503 |
| 30 | Increased cerebral lipofuscin (HP:0011813) | 2.66705315 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 2.64607604 |
| 32 | Hematochezia (HP:0002573) | 2.62860163 |
| 33 | Recurrent skin infections (HP:0001581) | 2.61914556 |
| 34 | Myocardial infarction (HP:0001658) | 2.60436641 |
| 35 | Encephalitis (HP:0002383) | 2.55124788 |
| 36 | Spondylolisthesis (HP:0003302) | 2.51885419 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.49808484 |
| 38 | Joint swelling (HP:0001386) | 2.49093757 |
| 39 | Pulmonary infiltrates (HP:0002113) | 2.48769504 |
| 40 | Abnormality of the nasal septum (HP:0000419) | 2.48561537 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.47871208 |
| 42 | Obstructive lung disease (HP:0006536) | 2.45846316 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.45846316 |
| 44 | Gingivitis (HP:0000230) | 2.44253291 |
| 45 | Interstitial pulmonary disease (HP:0006530) | 2.44061987 |
| 46 | Keratoconjunctivitis sicca (HP:0001097) | 2.43968805 |
| 47 | Combined immunodeficiency (HP:0005387) | 2.43935263 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.40960372 |
| 49 | Growth hormone excess (HP:0000845) | 2.40696361 |
| 50 | Cellulitis (HP:0100658) | 2.40313523 |
| 51 | Papilloma (HP:0012740) | 2.39689175 |
| 52 | Verrucae (HP:0200043) | 2.39689175 |
| 53 | Thyroiditis (HP:0100646) | 2.38228608 |
| 54 | Abnormality of the pleura (HP:0002103) | 2.37926881 |
| 55 | Epistaxis (HP:0000421) | 2.37438512 |
| 56 | Pulmonary fibrosis (HP:0002206) | 2.36626729 |
| 57 | Chest pain (HP:0100749) | 2.36228313 |
| 58 | Recurrent cutaneous fungal infections (HP:0011370) | 2.36225299 |
| 59 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.36225299 |
| 60 | Pustule (HP:0200039) | 2.34280371 |
| 61 | Anhidrosis (HP:0000970) | 2.32018878 |
| 62 | Arterial thrombosis (HP:0004420) | 2.30547520 |
| 63 | Stomatitis (HP:0010280) | 2.29252053 |
| 64 | Persistence of primary teeth (HP:0006335) | 2.28045965 |
| 65 | Dysostosis multiplex (HP:0000943) | 2.27433021 |
| 66 | Amyloidosis (HP:0011034) | 2.27311160 |
| 67 | Increased IgE level (HP:0003212) | 2.25294953 |
| 68 | Periodontitis (HP:0000704) | 2.24721985 |
| 69 | Urticaria (HP:0001025) | 2.22289398 |
| 70 | Gangrene (HP:0100758) | 2.22226333 |
| 71 | Alveolar cell carcinoma (HP:0006519) | 2.21435697 |
| 72 | Recurrent viral infections (HP:0004429) | 2.20974748 |
| 73 | Pulmonary embolism (HP:0002204) | 2.19170617 |
| 74 | Autoimmune thrombocytopenia (HP:0001973) | 2.18819351 |
| 75 | Chronic otitis media (HP:0000389) | 2.15730038 |
| 76 | Milia (HP:0001056) | 2.15669584 |
| 77 | Alopecia of scalp (HP:0002293) | 2.14017739 |
| 78 | Gastrointestinal inflammation (HP:0004386) | 2.13111035 |
| 79 | Episodic fever (HP:0001954) | 2.12208546 |
| 80 | Increased IgM level (HP:0003496) | 2.10779727 |
| 81 | Leukocytosis (HP:0001974) | 2.09185378 |
| 82 | Gingival bleeding (HP:0000225) | 2.06616781 |
| 83 | Spontaneous hematomas (HP:0007420) | 2.05053586 |
| 84 | Hemoptysis (HP:0002105) | 2.04496352 |
| 85 | Spinal cord lesions (HP:0100561) | 2.03360704 |
| 86 | Syringomyelia (HP:0003396) | 2.03360704 |
| 87 | Lip pit (HP:0100267) | 2.02969683 |
| 88 | Eosinophilia (HP:0001880) | 2.02309222 |
| 89 | Conical tooth (HP:0000698) | 2.01996480 |
| 90 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.01783530 |
| 91 | Osteomyelitis (HP:0002754) | 2.01342990 |
| 92 | Gastrointestinal infarctions (HP:0005244) | 2.00898046 |
| 93 | Arthralgia (HP:0002829) | 2.00572938 |
| 94 | Atrophic scars (HP:0001075) | 2.00432835 |
| 95 | Urethral obstruction (HP:0000796) | 1.99648901 |
| 96 | Submucous cleft hard palate (HP:0000176) | 1.98411405 |
| 97 | Gastrointestinal stroma tumor (HP:0100723) | 1.98060681 |
| 98 | Tetraparesis (HP:0002273) | 1.94571539 |
| 99 | Restrictive lung disease (HP:0002091) | 1.93712601 |
| 100 | Hypergammaglobulinemia (HP:0010702) | 1.93245921 |
| 101 | Abnormality of the frontal sinuses (HP:0002687) | 1.92898063 |
| 102 | Abnormality of glycolipid metabolism (HP:0010969) | 1.92682827 |
| 103 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.92682827 |
| 104 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.92682827 |
| 105 | Recurrent pneumonia (HP:0006532) | 1.91883592 |
| 106 | Pulmonary artery stenosis (HP:0004415) | 1.90794380 |
| 107 | Meningitis (HP:0001287) | 1.90248804 |
| 108 | Prolonged bleeding time (HP:0003010) | 1.90222114 |
| 109 | Polygenic inheritance (HP:0010982) | 1.89572627 |
| 110 | Premature rupture of membranes (HP:0001788) | 1.89509466 |
| 111 | Glomerulopathy (HP:0100820) | 1.88446459 |
| 112 | Glucose intolerance (HP:0000833) | 1.87982878 |
| 113 | Sepsis (HP:0100806) | 1.87729484 |
| 114 | Skin rash (HP:0000988) | 1.87602145 |
| 115 | Abnormality of the pericardium (HP:0001697) | 1.87351409 |
| 116 | Lymphopenia (HP:0001888) | 1.87008098 |
| 117 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.86827310 |
| 118 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86261037 |
| 119 | Cheilitis (HP:0100825) | 1.85939171 |
| 120 | Basal ganglia calcification (HP:0002135) | 1.85444932 |
| 121 | Xerostomia (HP:0000217) | 1.84996444 |
| 122 | Acute myeloid leukemia (HP:0004808) | 1.83162391 |
| 123 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82422854 |
| 124 | Vertebral compression fractures (HP:0002953) | 1.78796267 |
| 125 | Abnormality of T cell number (HP:0011839) | 1.78770966 |
| 126 | Plantar hyperkeratosis (HP:0007556) | 1.78245578 |
| 127 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.78208887 |
| 128 | Abnormality of eosinophils (HP:0001879) | 1.77503254 |
| 129 | Autoimmune hemolytic anemia (HP:0001890) | 1.77456598 |
| 130 | Skin ulcer (HP:0200042) | 1.77107321 |
| 131 | Aplasia cutis congenita (HP:0001057) | 1.76124933 |
| 132 | * Stomach cancer (HP:0012126) | 1.76099863 |
| 133 | Absent frontal sinuses (HP:0002688) | 1.75848172 |
| 134 | Petechiae (HP:0000967) | 1.73860328 |
| 135 | Axonal loss (HP:0003447) | 1.73789334 |
| 136 | Inflammation of the large intestine (HP:0002037) | 1.72752021 |
| 137 | Distal lower limb amyotrophy (HP:0008944) | 1.72536248 |
| 138 | Porencephaly (HP:0002132) | 1.72320573 |
| 139 | Esophageal varix (HP:0002040) | 1.71237015 |
| 140 | Colitis (HP:0002583) | 1.70928464 |
| 141 | Recurrent lower respiratory tract infections (HP:0002783) | 1.68139814 |
| 142 | Short nail (HP:0001799) | 1.67127368 |
| 143 | Bone pain (HP:0002653) | 1.66269031 |
| 144 | * Prostate neoplasm (HP:0100787) | 1.65785188 |
| 145 | Chronic diarrhea (HP:0002028) | 1.65591452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.80779952 |
| 2 | GRK6 | 2.79020109 |
| 3 | MAPK15 | 2.72396522 |
| 4 | TYK2 | 2.59915065 |
| 5 | IKBKB | 2.57623847 |
| 6 | TBK1 | 2.41002099 |
| 7 | TGFBR2 | 2.34704674 |
| 8 | IRAK4 | 2.34611531 |
| 9 | MAP3K3 | 2.28482194 |
| 10 | IKBKE | 2.28348370 |
| 11 | EPHB1 | 2.26024746 |
| 12 | PIK3CG | 2.22511018 |
| 13 | MST4 | 2.19300054 |
| 14 | IRAK3 | 2.16969576 |
| 15 | TXK | 2.11137190 |
| 16 | EPHA3 | 2.09821015 |
| 17 | CHUK | 2.06018978 |
| 18 | JAK3 | 2.04682330 |
| 19 | JAK1 | 1.93768551 |
| 20 | FES | 1.84775979 |
| 21 | KIT | 1.70006044 |
| 22 | STK10 | 1.58899849 |
| 23 | RPS6KA4 | 1.55202241 |
| 24 | TEC | 1.54857434 |
| 25 | PIM2 | 1.53762477 |
| 26 | NEK9 | 1.50325806 |
| 27 | PRPF4B | 1.43795751 |
| 28 | ITK | 1.41749618 |
| 29 | MAP2K2 | 1.40408504 |
| 30 | MAP4K1 | 1.40144143 |
| 31 | ERN1 | 1.37248893 |
| 32 | NLK | 1.36502437 |
| 33 | MAP2K3 | 1.33386265 |
| 34 | PBK | 1.27957406 |
| 35 | EPHA2 | 1.26849540 |
| 36 | FGFR3 | 1.24553057 |
| 37 | NUAK1 | 1.24372199 |
| 38 | TRPM7 | 1.23957863 |
| 39 | RIPK4 | 1.18768632 |
| 40 | BMPR1B | 1.17192225 |
| 41 | FGFR4 | 1.17026742 |
| 42 | BLK | 1.10429149 |
| 43 | FRK | 1.06215227 |
| 44 | BMPR2 | 1.06058857 |
| 45 | CSK | 1.05656175 |
| 46 | PIM1 | 1.05420382 |
| 47 | TNK2 | 1.04699712 |
| 48 | BTK | 1.02818871 |
| 49 | TGFBR1 | 1.02624114 |
| 50 | IRAK1 | 0.99942295 |
| 51 | HCK | 0.98366630 |
| 52 | ERBB3 | 0.98314339 |
| 53 | GRK7 | 0.96703455 |
| 54 | EIF2AK2 | 0.96334962 |
| 55 | TIE1 | 0.96027824 |
| 56 | PIK3CA | 0.90747171 |
| 57 | TESK2 | 0.89835160 |
| 58 | CSF1R | 0.86615302 |
| 59 | SIK3 | 0.84999422 |
| 60 | LCK | 0.84259521 |
| 61 | ZAK | 0.83664404 |
| 62 | ZAP70 | 0.82286069 |
| 63 | MST1R | 0.81418853 |
| 64 | MAP3K7 | 0.81409640 |
| 65 | MAPKAPK2 | 0.80032743 |
| 66 | MATK | 0.78951812 |
| 67 | MAP3K2 | 0.78938190 |
| 68 | MAP3K1 | 0.78927287 |
| 69 | MAPKAPK5 | 0.78644636 |
| 70 | STK24 | 0.75050047 |
| 71 | MAP3K13 | 0.74571827 |
| 72 | RPS6KA2 | 0.72717651 |
| 73 | RPS6KA5 | 0.70482687 |
| 74 | MAPK4 | 0.69083263 |
| 75 | MAPK7 | 0.68801032 |
| 76 | JAK2 | 0.68642543 |
| 77 | CDK12 | 0.65932913 |
| 78 | SYK | 0.65612505 |
| 79 | RPS6KC1 | 0.65075765 |
| 80 | RPS6KL1 | 0.65075765 |
| 81 | RIPK1 | 0.64907299 |
| 82 | CDK6 | 0.64880453 |
| 83 | MAPK12 | 0.64325873 |
| 84 | CDK8 | 0.63756916 |
| 85 | HIPK2 | 0.63091628 |
| 86 | MAPKAPK3 | 0.62247415 |
| 87 | CLK1 | 0.61094454 |
| 88 | PTK6 | 0.60668990 |
| 89 | GSK3A | 0.58563232 |
| 90 | STK3 | 0.58480581 |
| 91 | PRKD2 | 0.58381202 |
| 92 | MAP2K1 | 0.55921892 |
| 93 | PDGFRB | 0.55568464 |
| 94 | PRKG2 | 0.54194888 |
| 95 | PDK1 | 0.53711193 |
| 96 | ABL1 | 0.53635182 |
| 97 | MAP3K10 | 0.52481268 |
| 98 | RPS6KA6 | 0.52298552 |
| 99 | TTN | 0.51499598 |
| 100 | TAOK3 | 0.50928242 |
| 101 | DMPK | 0.50623564 |
| 102 | STK4 | 0.50317827 |
| 103 | VRK1 | 0.49560434 |
| 104 | EPHB2 | 0.49480582 |
| 105 | RPS6KB2 | 0.49402928 |
| 106 | LYN | 0.48951860 |
| 107 | MAPK3 | 0.48668579 |
| 108 | MAPK11 | 0.46975329 |
| 109 | MAP3K11 | 0.46731370 |
| 110 | MARK3 | 0.45826425 |
| 111 | TSSK6 | 0.45748596 |
| 112 | MARK2 | 0.45380882 |
| 113 | SIK2 | 0.43256354 |
| 114 | IRAK2 | 0.43065613 |
| 115 | PRKCD | 0.42415819 |
| 116 | BMX | 0.41804955 |
| 117 | IGF1R | 0.41021902 |
| 118 | RPS6KA1 | 0.40696939 |
| 119 | FER | 0.40524000 |
| 120 | KDR | 0.39466336 |
| 121 | ADRBK2 | 0.38963174 |
| 122 | PRKCQ | 0.38487174 |
| 123 | MOS | 0.37812915 |
| 124 | LRRK2 | 0.37320938 |
| 125 | PTK2B | 0.37199864 |
| 126 | MAP3K6 | 0.37070527 |
| 127 | CDC42BPA | 0.36738353 |
| 128 | NEK6 | 0.36353354 |
| 129 | FLT3 | 0.36087305 |
| 130 | PDK2 | 0.34874038 |
| 131 | TAOK2 | 0.33196590 |
| 132 | PDPK1 | 0.32337281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64926872 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.43425756 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.40824399 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.37836916 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.31307145 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.23420167 |
| 7 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.10665077 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.01402419 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.99226440 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.95469687 |
| 11 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.93196648 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.88194623 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.87722388 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.82574136 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.78293810 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.71275750 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60831054 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 1.60759062 |
| 19 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.58258251 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57127254 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55425813 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54516595 |
| 23 | Apoptosis_Homo sapiens_hsa04210 | 1.53584132 |
| 24 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.52983135 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.52934682 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43706777 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37895214 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36486921 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.34070967 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.34029938 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.33934822 |
| 32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.25187837 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.24735571 |
| 34 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.22764194 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22429943 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.22023884 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.20572819 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19492558 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.18971611 |
| 40 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.18209939 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15287878 |
| 42 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.14885609 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.12524776 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10128935 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.06472557 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.06119739 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04649518 |
| 48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.03679911 |
| 49 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.02731264 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 1.01137637 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00857899 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99844165 |
| 53 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.99839864 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.99834277 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90754508 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.90548059 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89193843 |
| 58 | Adherens junction_Homo sapiens_hsa04520 | 0.87917615 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86652354 |
| 60 | Focal adhesion_Homo sapiens_hsa04510 | 0.84342889 |
| 61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83854518 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81709653 |
| 63 | Prostate cancer_Homo sapiens_hsa05215 | 0.81075716 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.80722644 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79051685 |
| 66 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77791422 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76237626 |
| 68 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75590967 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70887623 |
| 70 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66781474 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65663183 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64633173 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63956912 |
| 74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63940890 |
| 75 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.63530403 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63365050 |
| 77 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.63317235 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62342240 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61503327 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58741212 |
| 81 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58638169 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55893620 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55182139 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54541103 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54130048 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53894323 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53436056 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53335183 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53275328 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52834674 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52375135 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51875470 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51359468 |
| 94 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.50980548 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50827343 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50562509 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47719152 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46724898 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45500345 |
| 100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44125128 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43894031 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43337338 |
| 103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42973345 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42696513 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.42464570 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41998161 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.41990618 |
| 108 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41419278 |
| 109 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40622185 |
| 110 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40495612 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40165853 |
| 112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40007936 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39778898 |
| 114 | Melanoma_Homo sapiens_hsa05218 | 0.39590471 |
| 115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36410332 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36174180 |
| 117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36174126 |
| 118 | Renin secretion_Homo sapiens_hsa04924 | 0.35940533 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32271752 |
| 120 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.30499024 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30320788 |
| 122 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.29895024 |

